ロード中...
Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion
The World Health Organization 2016 edition assigned anaplastic lymphoma kinase (ALK) rearrangement-associated renal cell carcinoma (ALK-RCC) as an emerging renal tumor entity. Identifying ALK-RCC is important because ALK inhibitors have been shown to be effective in treatment. Here, we report the ca...
保存先:
| 出版年: | Yonsei Med J |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Yonsei University College of Medicine
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7044692/ https://ncbi.nlm.nih.gov/pubmed/32102128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.3.262 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|